C81.98
Hodgkin lymphoma, unspecified, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Hodgkin lymphoma, also known as Hodgkin's disease, is a type of lymphoma, which is a cancer originating from lymphocytes, a type of white blood cell. The specific code C81.98 refers to Hodgkin lymphoma that affects lymph nodes across multiple sites in the body. While the exact cause is unknown, early detection and treatment are crucial for better outcomes. This condition typically presents with certain early signs and symptoms, and various diagnostic procedures are used to confirm the diagnosis. Treatment options generally involve chemotherapy, radiation therapy, or other targeted treatments aimed at eliminating cancerous cells and managing symptoms.
Causes & Symptoms
Clinical Causes: Genetic predisposition may increase risk. Previous exposure to certain viruses, such as Epstein-Barr virus (EBV). Family history of Hodgkin or other lymphomas. Immunodeficiency conditions that weaken the immune system. Environmental factors, though specific risk factors are not well-established.
Key Symptoms: Swollen lymph nodes in the neck, armpits, or groin that are painless. Unexplained weight loss over a short period. Persistent fatigue or feeling unusually tired. Fever that comes and goes without a clear cause. Night sweats, often severe enough to soak clothing or bedding. Itching all over the body. Localized pain or discomfort when drinking alcohol. Reduced appetite or a feeling of fullness due to enlarged lymph nodes. Unexplained cough, chest pain, or difficulty breathing if thoracic lymph nodes are involved.
Diagnostic & Treatment
Diagnosis Path: Lymph node biopsy: Removing and examining tissue for Hodgkin-specific Reed-Sternberg cells. Imaging tests: PET scans, CT scans, and sometimes MRI to determine the extent and sites of disease involvement. Blood tests: To evaluate overall health, organ function, and identify any abnormalities. Bone marrow examination: In some cases, to assess if the disease has spread to the marrow.
Treatment Protocols: Chemotherapy: Using drugs to kill or control the growth of lymphoma cells. Radiation therapy: Targeted radiation to affected lymph node areas to destroy remaining cancer cells. Immunotherapy: Employing drugs that help the immune system recognize and attack cancer cells, often used in specific cases. Targeted therapy: Using agents that target specific molecules involved in the growth of the cancer. Stem cell transplant: Considered in cases of relapse or refractory disease, involving the replacement of diseased marrow with healthy stem cells.
Clinical Advice & FAQs
Billing Guidance
Is C81.98 a billable ICD-10 code?
Yes, C81.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.98?
Clinical documentation must specify the nature of Hodgkin lymphoma, unspecified, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference